Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Apr 2020 07:00

RNS Number : 0917J
Tavistock Investments PLC
08 April 2020
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Trading Update

8th April 2020

The Company is pleased to advise that its trading result for the year ended 31 March 2020 is expected to be in line with the market's expectation for continued growth in reported EBITDA.

One particular highlight of the year has been the superb performance of the Company's new range of protected UCITS funds. They were designed specifically to shield clients from the potentially disastrous consequences of sudden and sustained falls in market values, offering investors an alternative, more prudent approach to medium to long term investing.

The ACUMEN Capital Protection Portfolio and the ACUMEN ESG Protection Portfolio provide a guaranteed level of protection for investors equivalent to 90% of each fund's highest ever value (Net Asset Value or NAV). These guarantees are contractually underwritten by Morgan Stanley & Co International Plc.

By way of illustration, between 1st January and 31st March 2020, the FTSE fell 24%. By contrast, these two protected funds fell by less than 5% and 3% respectively.

As of Monday, an investment made in the ACUMEN Capital Protection Portfolio risked a maximum potential loss of only 3.6% of the initial investment, whilst still benefiting from the 90% high watermark guarantee going forward.

However, the COVID-19 pandemic has caused commercial conditions to become extremely challenging. It is inevitable that adverse economic and market performance, together with the commercial consequences of social distancing and the Government imposed lock-down, will combine to have a detrimental effect on the Company's performance in the new financial year. The impact of the pandemic will be felt for some considerable time, potentially through several iterations, and at the moment it is impossible to accurately assess the consequences.

In light of this uncertainty, the Board has adopted a number of measures to protect profitability and ensure that the business emerges from the current crises in the best working order. No dividend will be paid at the present time and a comprehensive strategic review is also being undertaken with a view to removing cost from the business. This exercise will encompass a pragmatic impairment review of the carrying value of intangible assets on the Company's Balance Sheet.

Every member of the executive team has volunteered to waive a significant proportion of their income, with immediate effect, so that everyone in the business understands that we will deal with the challenges ahead together.

Pending stability in the financial markets, the Company has withdrawn its guidance for market expectation in the year to 31 March 2021.

Brian Raven, the Company's Chief Executive, said:

"The key measure of leadership is how well it performs under difficult circumstances. Tavistock is led by a strong, experienced and unified team who have clearly demonstrated their commitment to the business and its staff.

We continue to look after the financial advice needs of our tens of thousands of underlying clients, and to manage their assets in our customary active, efficient and disciplined manner.

Market turbulence is far from over and a potentially very deep recession lies ahead.

A great many clients, particularly the less well off, cannot afford to risk further significant losses to savings or pension pots. These clients need security, ahead of investment upside potential. I believe that Tavistock's ACUMEN Protection Portfolios offer a safe haven solution for these cautious investors in these very difficult times. Whilst the funds primary purpose is to protect the downside, they will also be automatically, but gradually, reinvested from cash into higher risk assets, as market volatility reduces."

 

Ends

 

Enquiries

Tavistock Investments Plc

Oliver Cooke

Brian Raven

Tel: 01753 867000

 

Arden Partners Plc

Paul Shackleton

Tel: 020 7614 5900

Allenby Capital Limited

Nick Naylor

Nick Athanas

Tel: 020 3328 5656

Vested

Elspeth Rothwell

Tel: 020 3890 8118

 

(Mobile): 07811 375 998

Amelia Graham

(Mobile): 07393 477 057

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFEFSEIDIII
Date   Source Headline
12th Mar 20217:00 amRNSNotice of GM
11th Mar 20217:00 amRNSRescheduling of General Meeting
1st Mar 20217:00 amRNSNotice of GM
10th Feb 202112:01 pmRNSLetter to shareholders
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:00 pmRNSPrice Monitoring Extension
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSDirector/PDMR Shareholding
4th Dec 20207:00 amRNSPostponement of general meeting
20th Nov 20207:00 amRNSNotice of GM
10th Nov 20207:00 amRNSInterim Results
23rd Sep 202012:15 pmRNSResult of AGM & GM
14th Sep 20207:00 amRNSCorrection to no. of shares admitted to trading
9th Sep 20207:00 amRNSAppointment of Nominated Adviser & Rule 17 update
28th Aug 20207:00 amRNSNotice of AGM
23rd Jul 20209:07 amRNSFinal Results For Year Ended 31 March 2020
23rd Jul 20207:00 amRNSFinal Results For Year Ended 31 March 2020
24th Jun 20207:00 amRNSTrading Update
8th Apr 20207:00 amRNSTrading Update
19th Mar 202010:52 amRNSDirector/PDMR Shareholding
19th Mar 202010:01 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSIssue of Shares to Strategic Investor
21st Nov 20197:00 amRNSInterim Results
1st Oct 20194:35 pmRNSDirector/PDMR Shareholding
30th Sep 201911:44 amRNSDirector/PDMR Shareholding
27th Sep 20196:09 pmRNSDirector/PDMR Shareholding
27th Sep 20197:00 amRNSTrading Update And Entry Into Loan Facility
25th Sep 20193:44 pmRNSResult of AGM
4th Sep 201912:11 pmRNSNotice of AGM
3rd Sep 20197:00 amRNSChange of Auditor
30th May 201911:49 amRNSTermination of Strategic Alliance with Lighthouse
15th May 20191:17 pmRNSPayment of Maiden Interim Dividend
15th May 20197:00 amRNSFinal Results
13th May 20197:00 amRNSNotice of results
9th May 20198:56 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSPre-Close Trading Update
23rd Nov 20187:00 amRNSHolding(s) in Company
23rd Nov 20187:00 amRNSHolding(s) in Company
19th Nov 20185:47 pmRNSHolding(s) in Company
14th Nov 20187:30 amRNSResult of £1.25m Fundraise
14th Nov 20187:00 amRNSStrategic Alliance and Proposed Fundraise
8th Nov 20185:29 pmRNSCorrection to Interim Results
8th Nov 20187:00 amRNSInterim Results
1st Oct 20184:26 pmRNSHolding(s) in Company
26th Sep 201812:35 pmRNSResult of AGM
30th Aug 20181:10 pmRNSNotice of AGM
27th Jul 201812:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.